Summary: The Neuwave Microwave Ablation System is a device used for tumor ablation. It is primarily used in the treatment of liver tumors and other solid tumors. Key evidence highlights its safety and efficacy in various clinical settings.
The Neuwave Microwave Ablation System was cleared by the FDA through the 510(k) pathway on August 11, 2022. It is manufactured by Neuwave Medical and is classified as a Class 2 medical device.
What It Is
The Neuwave Microwave Ablation System is a medical device designed for the ablation of soft tissue tumors using microwave energy. It is intended for use in clinical settings to treat tumors in organs such as the liver and lungs.
Clinical Applications
Common clinical scenarios for the Neuwave Microwave Ablation System include the treatment of hepatocellular carcinoma and other solid tumors where surgical resection is not feasible. It is often used in interventional radiology and oncology departments.
Evidence Summary
The available literature includes 15 studies, comprising prospective and comparative studies, with publication years ranging from 2022 to 2026. These studies evaluate the safety, efficacy, and cost-effectiveness of the device in various clinical applications.
Reported Outcomes
Published studies report that the Neuwave Microwave Ablation System is effective in creating ablation zones in liver tumors, with comparable efficacy to other microwave systems. It has been shown to be a viable alternative to radiofrequency ablation in certain clinical settings.
Safety Profile
Reported complications include minimal adverse events, with studies indicating a favorable safety profile. The device has been assessed for safety in both human and animal models, showing low incidence of complications.
Evidence Limitations
The evidence is limited by the small sample sizes and the need for longer-term follow-up studies to fully assess the long-term efficacy and safety. Further research is needed to compare the device with other ablation technologies in diverse patient populations.
Linked Studies (5)
PubMed • 2023
Comparative Study of Ablation Zone of EMPRINT HP Microwave Device with Contemporary 2.4 GHz Microwave Devices in an Ex Vivo Porcine Liver Model.
What are the clinical indications for Neuwave Microwave Ablation System?
The device is indicated for the ablation of soft tissue tumors, including hepatocellular carcinoma and other solid tumors where surgical options are limited.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective tumor ablation with the Neuwave system, demonstrating comparable efficacy to other microwave ablation systems and radiofrequency ablation.
What complications have been reported?
Safety data from studies indicate minimal complications, with a favorable safety profile observed in both human and animal studies.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.